{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:38:14Z","timestamp":1783604294364,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology &amp; Behavior"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.physbeh.2012.03.014","type":"journal-article","created":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T15:02:30Z","timestamp":1332169350000},"page":"574-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Exendin-4 decreases amphetamine-induced locomotor activity"],"prefix":"10.1016","volume":"106","author":[{"given":"Kevin","family":"Erreger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeola R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Poe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel H.","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg D.","family":"Stanwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2012.03.014_bb0005","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0010","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.molmed.2008.01.003","article-title":"Glucagon-like peptide-1, glucose homeostasis and diabetes","volume":"14","author":"Holst","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0020","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","article-title":"Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas","volume":"267","author":"Eng","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0025","doi-asserted-by":"crossref","first-page":"19650","DOI":"10.1016\/S0021-9258(19)36565-2","article-title":"Exendin-4 is a high potency agonist and truncated exendin-(9\u201339)-amide an antagonist at the glucagon-like peptide 1-(7\u201336)-amide receptor of insulin-secreting beta-cells","volume":"268","author":"Goke","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0030","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1210\/endo.136.8.7628397","article-title":"Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV","volume":"136","author":"Kieffer","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.ijo.0802206","article-title":"Entry of exendin-4 into brain is rapid but may be limited at high doses","volume":"27","author":"Kastin","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1385\/JMN:18:1-2:07","article-title":"Interactions of glucagon-like peptide-1 (GLP-1) with the blood\u2013brain barrier","volume":"18","author":"Kastin","year":"2002","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0045","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1210\/en.2011-0174","article-title":"Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4","volume":"152","author":"Kanoski","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0050","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1046\/j.1471-4159.1996.66030920.x","article-title":"Expression of the glucagon-like peptide-1 receptor gene in rat brain","volume":"66","author":"Alvarez","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0060","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/cne.902710405","article-title":"Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study","volume":"271","author":"Jin","year":"1988","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0065","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0306-4522(96)00434-4","article-title":"Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem","volume":"77","author":"Larsen","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuroscience.2011.02.023","article-title":"Preproglucagon neurons project widely to autonomic control areas in the mouse brain","volume":"180","author":"Llewellyn-Smith","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2010.03.059","article-title":"Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure","volume":"1350","author":"Rinaman","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2012.03.014_bb0080","doi-asserted-by":"crossref","first-page":"14453","DOI":"10.1523\/JNEUROSCI.3262-11.2011","article-title":"Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake","volume":"31","author":"Dossat","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0085","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/en.2011-1443","article-title":"GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake","volume":"153","author":"Alhadeff","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0090","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.cmet.2011.09.010","article-title":"The gut hormones PYY(3\u201336) and GLP-1(7\u201336 amide) reduce food intake and modulate brain activity in appetite centers in humans","volume":"14","author":"De Silva","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0095","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/379069a0","article-title":"A role for glucagon-like peptide-1 in the central regulation of feeding","volume":"379","author":"Turton","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0105","doi-asserted-by":"crossref","unstructured":"Volkow ND, Wang GJ, Fowler JS, Tomasi D, Baler R. Food and drug reward: overlapping circuits in human obesity and addiction. Curr Top Behav Neurosci in press, doi:10.1007\/7854_2011_169.","DOI":"10.1007\/7854_2011_169"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0110","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrn3105","article-title":"Common cellular and molecular mechanisms in obesity and drug addiction","volume":"12","author":"Kenny","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neuron.2006.01.016","article-title":"Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine","volume":"49","author":"Borgland","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1369-1600.2007.00053.x","article-title":"Ghrelin: a link between energy homeostasis and drug abuse?","volume":"12","author":"Cummings","year":"2007","journal-title":"Addict Biol"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainres.2010.04.028","article-title":"Modulation of the mesolimbic dopamine system by leptin","volume":"1350","author":"Opland","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0130","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1210\/en.2008-0180","article-title":"Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure","volume":"149","author":"Knauf","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0135","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/sj.ijo.0803284","article-title":"Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures","volume":"30","author":"Mack","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0140","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/jn\/131.8.2164","article-title":"A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats","volume":"131","author":"Peters","year":"2001","journal-title":"J Nutr"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0145","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/diabetes.48.5.1026","article-title":"Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob\/ob, db\/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta)","volume":"48","author":"Young","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0150","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1371\/journal.pbio.0050274","article-title":"Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine","volume":"5","author":"Williams","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00421062","article-title":"Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat","volume":"41","author":"Pijnenburg","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0160","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00213-002-1288-7","article-title":"Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats","volume":"165","author":"Shoblock","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0165","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ddr.1195","article-title":"Pharmacokinetic actions of exendin-4 in the rat: comparison with glucagon-like peptide-1","volume":"53","author":"Parkes","year":"2001","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0170","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0031-9384(92)90368-C","article-title":"Behavioral conditioned responses to contextual and odor stimuli paired with LiCl administration","volume":"52","author":"Meachum","year":"1992","journal-title":"Physiol Behav"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0175","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1037\/0735-7044.106.2.294","article-title":"Place conditioning in a three- or four-choice apparatus: role of stimulus novelty in drug-induced place conditioning","volume":"106","author":"Parker","year":"1992","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2005.04.007","article-title":"Dose response effects of lithium chloride on conditioned place aversions and locomotor activity in rats","volume":"515","author":"Tenk","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI990","article-title":"Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans","volume":"101","author":"Flint","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0190","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0091-3057(98)00032-X","article-title":"Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake","volume":"61","author":"Halford","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0195","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1523\/JNEUROSCI.23-15-06163.2003","article-title":"CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors","volume":"23","author":"Kinzig","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0200","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1523\/JNEUROSCI.20-04-01616.2000","article-title":"The role of CNS glucagon-like peptide-1 (7\u201336) amide receptors in mediating the visceral illness effects of lithium chloride","volume":"20","author":"Seeley","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0205","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0091-3057(88)90413-3","article-title":"Thigmotaxis as a test for anxiolytic activity in rats","volume":"31","author":"Treit","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0210","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0006-8993(03)02986-X","article-title":"Viral restoration of dopamine to the nucleus accumbens is sufficient to induce a locomotor response to amphetamine","volume":"980","author":"Heusner","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0215","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.npp.1300678","article-title":"Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists","volume":"30","author":"Chartoff","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0220","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1053\/meta.2000.6251","article-title":"Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats","volume":"49","author":"Rodriquez de Fonseca","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0225","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/00071660120109971","article-title":"Intracerebroventricular injection of glucagon-like peptide-1 decreases monoamine concentrations in the hypothalamus of chicks","volume":"43","author":"Tachibana","year":"2002","journal-title":"Br Poult Sci"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0230","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrendo.2011.77","article-title":"GLP-1 and energy balance: an integrated model of short-term and long-term control","volume":"7","author":"Barrera","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0235","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1172\/JCI25764","article-title":"Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage","volume":"115","author":"Knauf","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0240","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1172\/JCI0215595","article-title":"Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons","volume":"110","author":"Yamamoto","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0245","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1210\/en.2007-1743","article-title":"Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation","volume":"149","author":"Hayes","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0250","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1210\/en.2009-0915","article-title":"GLP-1(7\u201336)-amide and Exendin-4 stimulate the HPA axis in rodents and humans.","volume":"151","author":"Gil-Lozano","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0255","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.expneurol.2007.11.016","article-title":"Role of central glucagon-like peptide-1 in hypothalamo\u2013pituitary\u2013adrenocortical facilitation following chronic stress","volume":"210","author":"Tauchi","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0260","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jpsychires.2007.08.007","article-title":"Failure of glucagon-like peptide-1 to induce panic attacks or anxiety in patients with panic disorder","volume":"42","author":"Strawn","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0265","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jdiacomp.2011.03.002","article-title":"Psychological and quality of life changes in patients using GLP-1 analogues","volume":"25","author":"Grant","year":"2011","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0270","doi-asserted-by":"crossref","first-page":"R981","DOI":"10.1152\/ajpregu.00449.2007","article-title":"GLP-1 analogs: satiety without malaise?","volume":"293","author":"Tang-Christensen","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0275","first-page":"R23","article-title":"PVN infusion of GLP-1-(7\u201336) amide suppresses feeding but does not induce aversion or alter locomotion in rats","volume":"274","author":"McMahon","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0280","first-page":"R726","article-title":"Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats","volume":"272","author":"Thiele","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0285","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2337\/diacare.22.7.1137","article-title":"Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients","volume":"22","author":"Toft-Nielsen","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0290","first-page":"R1541","article-title":"Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2","volume":"276","author":"Gutzwiller","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0295","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.ijo.0800818","article-title":"Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men","volume":"23","author":"Naslund","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0300","doi-asserted-by":"crossref","first-page":"R983","DOI":"10.1152\/ajpregu.00323.2007","article-title":"The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size","volume":"293","author":"Scott","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0305","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrn1406","article-title":"Dopamine, learning and motivation","volume":"5","author":"Wise","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0310","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.ps.40.020189.001203","article-title":"Brain dopamine and reward","volume":"40","author":"Wise","year":"1989","journal-title":"Annu Rev Psychol"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0315","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","article-title":"A psychomotor stimulant theory of addiction","volume":"94","author":"Wise","year":"1987","journal-title":"Psychol Rev"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0320","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1523\/JNEUROSCI.22-09-03312.2002","article-title":"Psychomotor stimulant addiction: a neural systems perspective","volume":"22","author":"Everitt","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0325","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/db06-0565","article-title":"Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not","volume":"56","author":"Raun","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.physbeh.2012.03.014_bb0330","doi-asserted-by":"crossref","first-page":"389","DOI":"10.31887\/DCNS.2007.9.4\/pkalivas","article-title":"Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity","volume":"9","author":"Kalivas","year":"2007","journal-title":"Dialogues Clin Neurosci"}],"container-title":["Physiology &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938412001199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938412001199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:58:15Z","timestamp":1758477495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938412001199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0031938412001199"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2012.03.014","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exendin-4 decreases amphetamine-induced locomotor activity","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2012.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}